Nasopharyngeal Neoplasms: all 242 studies
Page 1 of 3. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal CarcinomaNot yet recruitingNCT07650266Phase 1
- Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck TumorsRecruitingNCT07625423Phase 1
- Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate in Transoral SurgeryNot yet recruitingNCT07552545Not applicable
- Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT07524413Phase 3
- Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal CarcinomaNot yet recruitingNCT07385079Phase 3
- Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal CarcinomaNot yet recruitingNCT07373990Phase 3
- PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPCRecruitingNCT07332247Phase 2
- AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective StudyRecruitingNCT07326358
- Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)RecruitingNCT07277764Phase 2
- AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)RecruitingNCT07038343Phase 1/2
- JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal CancerNot yet recruitingNCT06892431Phase 2
- Trop2-targeted immunoPET Imaging of Solid TumorsRecruitingNCT06851663Phase 2/3
- Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPCRecruitingNCT06811844Phase 2
- EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal CarcinomaRecruitingNCT06802835Phase 1/2
- Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal CancerNot yet recruitingNCT06775756Phase 3
- QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.RecruitingNCT06749899Phase 3
- IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal CarcinomaEnrolling by invitationNCT06688175Phase 2
- Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal CarcinomaRecruitingNCT06682442Not applicable
- Arabic PRO Measures for Head and Neck Cancer Radiotherapy.RecruitingNCT06662929
- U87 CAR-T in Patients With Advanced Head and Neck TumorsRecruitingNCT06614686Phase 1
- GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPCNot yet recruitingNCT06611826Phase 2
- Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous PolyposisRecruitingNCT06545526Phase 3
- Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam TherapyNot yet recruitingNCT06480903
- Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life StudyNot yet recruitingNCT06472024Not applicable
- A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal CancerRecruitingNCT06457503Phase 4
- Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous PolyposisRecruitingNCT06435533Not applicable
- Adebrelimab and Chemoradiotherapy in High-risk LANPCRecruitingNCT06349889Phase 2
- The Protection of Thyroid Function in IMRT for Nasopharyngeal CarcinomaRecruitingNCT06268600Not applicable
- Inherited Cancer Early Diagnosis (ICED) StudyRecruitingNCT06163365
- Nivolumab in Children and Adults With Nasopharyngeal CarcinomaRecruitingNCT06019130Phase 2
- Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsRecruitingNCT05983432Phase 1
- A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in ChinaRecruitingNCT05638269
- Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICTRecruitingNCT05628922Phase 2
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- The Head and Neck Registry of the European Reference Network on Rare Adult Solid CancersRecruitingNCT05483374
- Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal CarcinomaRecruitingNCT05385926Phase 2
- Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal CancerRecruitingNCT05305131Phase 2
- Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line ChemotherapyRecruitingNCT04978012Phase 2
- Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based TreatmentRecruitingNCT04875611Phase 2
- Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal CarcinomaNot yet recruitingNCT04870905Phase 2
- Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal CarcinomaRecruitingNCT04453826Phase 3
- Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsRecruitingNCT04340024
- Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous PolyposisRecruitingNCT03471403
- Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma PatientsRecruitingNCT03353467Not applicable
- Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic LesionsRecruitingNCT03129412Phase 2
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
- Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersRecruitingNCT00900419
- A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTerminatedNCT05070247Phase 1/2Results posted
- Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)CompletedNCT03924986Phase 3Results posted
- Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)TerminatedNCT03769467Phase 1/2Results posted
- A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal PolyposisCompletedNCT03688555Phase 2Results posted
- Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)TerminatedNCT03682055Phase 1/2Results posted
- Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal PolyposisCompletedNCT03401229Phase 3Results posted
- Sirolimus and Familial Adenomatous Polyposis (FAP)CompletedNCT03095703Phase 2Results posted
- Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaCompletedNCT03082534Phase 2Results posted
- Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon CancerCompletedNCT02961374Phase 2Results posted
- Avelumab for Recurrent/Metastatic Nasopharyngeal CancerTerminatedNCT02875613Phase 2Results posted
- Study to Evaluate Multiple Doses in Patients With Nasal PolyposisCompletedNCT02734849Phase 2Results posted
- Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)CompletedNCT02611960Phase 3Results posted
- Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck CancerCompletedNCT02589938Not applicableResults posted
- The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus SurgeryCompletedNCT02562924Not applicableResults posted
- Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal CarcinomaCompletedNCT02269943Phase 2Results posted
- Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and NeckCompletedNCT02113878Phase 1Results posted
- Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis NasiCompletedNCT01946711Phase 1/2Results posted
- 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
- Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess SafetyCompletedNCT01622569Phase 3Results posted
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)CompletedNCT01483144Phase 3Results posted
- Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With PolyposisCompletedNCT01197612Phase 3Results posted
- A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsCompletedNCT01187901Phase 2Results posted
- Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)CompletedNCT00927485Not applicableResults posted
- Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)CompletedNCT00770991Phase 1Results posted
- To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal CancerCompletedNCT00697619Phase 2Results posted
- Curcumin in Treating Patients With Familial Adenomatous PolyposisCompletedNCT00641147Phase 2Results posted
- A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal CancerCompletedNCT00603915Phase 2Results posted
- Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)TerminatedNCT00585312Phase 3Results posted
- Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and AdolescentsCompletedNCT00565448Phase 2Results posted
- Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPACompletedNCT00510692Phase 2/3Results posted
- Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal CancerCompletedNCT00408694Phase 2Results posted
- Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control PatientsTerminatedNCT00151476Results posted
- Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis CancersCompletedNCT00141765Phase 2Results posted
- Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal CancerCompletedNCT00057785Phase 2Results posted
- Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous PolyposisCompletedNCT00033371Phase 2Results posted
- The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant TumorsActive, not recruitingNCT07890038
- Oral Mucositis Management in Patients Receiving Radiation for Head and Neck Cancer: An Evaluation of a Barrier Based TreatmentActive, not recruitingNCT07697287Phase 4
- 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma PatientsCompletedNCT07139054
- Impact of Vitamin D on Therapeutic Respons in NPC Chemoradiated PatientsActive, not recruitingNCT07042711Not applicable
- Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher ImmunotherapyActive, not recruitingNCT06414577Phase 2
- Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT05807880Phase 2
- Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)Active, not recruitingNCT05587374Phase 3
- Somatostatin Receptor Imaging in NPC, EBV Related CancersCompletedNCT05581550Not applicable
- Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal CancerCompletedNCT05564286Phase 3
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）CompletedNCT05436275Phase 3
- The CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous PolyposisCompletedNCT05402891Phase 2
- Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal CancerActive, not recruitingNCT05261750Phase 1/2
- P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsActive, not recruitingNCT05239143Phase 1
- To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal CancerStatus unknownNCT05198531Phase 1/2
- Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-inSuspendedNCT05198479Phase 2
- Nasality Evolution in a Nasal Polyposis Context : Multiparametric Evaluation : Articulatory (Imaging), Aerodynamics, Acoustics and PerceptionStatus unknownNCT05131958